|
Volumn 178, Issue APR., 2001, Pages 317-324
|
Chronic benzodiazepine use in general practice patients with depression: An evaluation of controlled treatment and taper-off - Report on behalf of the Dutch Chronic Benzodiazepine Working Group
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE DERIVATIVE;
DIAZEPAM;
PAROXETINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DEPRESSION;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG WITHDRAWAL;
FEMALE;
FINANCIAL MANAGEMENT;
FOLLOW UP;
GENERAL PRACTICE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRESCRIPTION;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-ANXIETY AGENTS;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
DEPRESSIVE DISORDER;
DIAZEPAM;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PAROXETINE;
SAMPLE SIZE;
SEROTONIN UPTAKE INHIBITORS;
SUBSTANCE WITHDRAWAL SYNDROME;
|
EID: 0035073469
PISSN: 00071250
EISSN: None
Source Type: Journal
DOI: 10.1192/bjp.178.4.317 Document Type: Article |
Times cited : (83)
|
References (23)
|